141 related articles for article (PubMed ID: 27488213)
1. Use of PlasmaJet for Peritoneal Carcinomatosis in Ovarian Cancer.
Panuccio E; Leunen K; Van Nieuwenhuysen E; Neven P; Lambrechts S; Vergote I
Int J Gynecol Cancer; 2016 Oct; 26(8):1521-4. PubMed ID: 27488213
[TBL] [Abstract][Full Text] [Related]
2. Primary debulking surgery of the upper abdomen and the diaphragm, with a plasma device surgery system, for advanced ovarian cancer.
Cordeiro Vidal G; Babin G; Querleu D; Guyon F
Gynecol Oncol; 2017 Jan; 144(1):223-224. PubMed ID: 27836207
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and safety of the PlasmaJet® Device in advanced stage ovarian carcinoma: a systematic review.
Nieuwenhuyzen-de Boer GM; van der Kooy J; van Beekhuizen HJ
J Ovarian Res; 2019 Jul; 12(1):71. PubMed ID: 31362769
[TBL] [Abstract][Full Text] [Related]
4. A novel technique: Carbon dioxide gas-assisted total peritonectomy, diaphragm and intestinal meso stripping in open surgery for advanced ovarian cancer (Çukurova technique).
Khatib G; Guzel AB; Gulec UK; Vardar MA
Gynecol Oncol; 2017 Sep; 146(3):674-675. PubMed ID: 28720378
[TBL] [Abstract][Full Text] [Related]
5. Total parietal peritonectomy with en bloc pelvic resection for advanced ovarian cancer with peritoneal carcinomatosis.
Kim HS; Bristow RE; Chang SJ
Gynecol Oncol; 2016 Dec; 143(3):688-689. PubMed ID: 27743737
[TBL] [Abstract][Full Text] [Related]
6. The Emerging Role of Neutral Argon Plasma (PlasmaJet) in the Treatment of Advanced Stage Ovarian Cancer: A Systematic Review.
Prodromidou A; Pandraklakis A; Iavazzo C
Surg Innov; 2020 Jun; 27(3):299-306. PubMed ID: 32129144
[No Abstract] [Full Text] [Related]
7. Experience with PlasmaJet™ in debulking surgery in 87 patients with advanced-stage ovarian cancer.
Volcke A; Van Nieuwenhuysen E; Han S; Salihi R; Van Gorp T; Vergote I
J Surg Oncol; 2021 Mar; 123(4):1109-1114. PubMed ID: 33497468
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of effectiveness of the PlasmaJet surgical device in the treatment of advanced stage ovarian cancer (PlaComOv-study): study protocol of a randomized controlled trial in the Netherlands.
Nieuwenhuyzen-de Boer GM; Hofhuis W; Reesink-Peters N; Ewing-Graham PC; Schoots IG; Beltman JJ; Piek JMJ; Baalbergen A; Kooi GS; van Haaften A; van Huisseling H; Haans L; Dorman M; van Beekhuizen HJ
BMC Cancer; 2019 Jan; 19(1):58. PubMed ID: 30642296
[TBL] [Abstract][Full Text] [Related]
9. A Comparison of Thermal Plasma Energy Versus Argon Beam Coagulator-Induced Intestinal Injury After Vaporization in a Porcine Model.
Tanner EJ; Dun E; Sonoda Y; Olawaiye AB; Chi DS
Int J Gynecol Cancer; 2017 Jan; 27(1):177-182. PubMed ID: 27922979
[TBL] [Abstract][Full Text] [Related]
10. Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
Robella M; Vaira M; Marsanic P; Mellano A; Borsano A; Cinquegrana A; Sottile A; De Simone M
Minerva Chir; 2014 Feb; 69(1):27-35. PubMed ID: 24675244
[TBL] [Abstract][Full Text] [Related]
11. Optimal cytoreduction with neutral argon plasma energy in selected patients with ovarian and primitive peritoneal cancer.
Renaud MC; Sebastianelli A
J Obstet Gynaecol Can; 2013 Jan; 35(1):49-52. PubMed ID: 23343797
[TBL] [Abstract][Full Text] [Related]
12. Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): a feasibility study.
Gueli Alletti S; Bottoni C; Fanfani F; Gallotta V; Chiantera V; Costantini B; Cosentino F; Ercoli A; Scambia G; Fagotti A
Am J Obstet Gynecol; 2016 Apr; 214(4):503.e1-503.e6. PubMed ID: 26529370
[TBL] [Abstract][Full Text] [Related]
13. Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center.
Muñoz-Casares FC; Medina-Fernández FJ; Arjona-Sánchez Á; Casado-Adam Á; Sánchez-Hidalgo JM; Rubio MJ; Ortega-Salas R; Muñoz-Villanueva MC; Rufián-Peña S; Briceño FJ
Eur J Surg Oncol; 2016 Feb; 42(2):224-33. PubMed ID: 26673283
[TBL] [Abstract][Full Text] [Related]
14. Routine second-look after surgical treatment of colonic peritoneal carcinomatosis.
Delhorme JB; Triki E; Romain B; Meyer N; Rohr S; Brigand C
J Visc Surg; 2015 Jun; 152(3):149-54. PubMed ID: 25650364
[TBL] [Abstract][Full Text] [Related]
15. Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncology Group Study JCOG0602.
Onda T; Satoh T; Saito T; Kasamatsu T; Nakanishi T; Nakamura K; Wakabayashi M; Takehara K; Saito M; Ushijima K; Kobayashi H; Kawana K; Yokota H; Takano M; Takeshima N; Watanabe Y; Yaegashi N; Konishi I; Kamura T; Yoshikawa H;
Eur J Cancer; 2016 Sep; 64():22-31. PubMed ID: 27323348
[TBL] [Abstract][Full Text] [Related]
16. Functional tumour burden of peritoneal carcinomatosis derived from DWI could predict incomplete tumour debulking in advanced ovarian carcinoma.
Lee EYP; An H; Perucho JAU; Chiu KWH; Hui ES; Chu MMY; Ngan HYS
Eur Radiol; 2020 Oct; 30(10):5551-5559. PubMed ID: 32405751
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant Use of PlasmaJet Device During Cytoreductive Surgery for Advanced-Stage Ovarian Cancer: Results of the PlaComOv-study, a Randomized Controlled Trial in The Netherlands.
Nieuwenhuyzen-de Boer GM; Hofhuis W; Reesink-Peters N; Willemsen S; Boere IA; Schoots IG; Piek JMJ; Hofman LN; Beltman JJ; van Driel WJ; Werner HMJ; Baalbergen A; van Haaften-de Jong AMLD; Dorman M; Haans L; Nedelcu I; Ewing-Graham PC; van Beekhuizen HJ
Ann Surg Oncol; 2022 Aug; 29(8):4833-4843. PubMed ID: 35552938
[TBL] [Abstract][Full Text] [Related]
18. The integrated treatment of peritoneal carcinomatosis. A preliminary experience.
Cavaliere F; Di Filippo F; Cosimelli M; Aloe L; Arcuri E; Anzà M; Callopoli A; Di Lauro L; Morace E; Botti C; Natoli S; Tedesco M; Giunta S; Cavaliere R
J Exp Clin Cancer Res; 1999 Jun; 18(2):151-8. PubMed ID: 10464701
[TBL] [Abstract][Full Text] [Related]
19. Computed tomography as a predictor of the extent of the disease and surgical outcomes in ovarian cancer.
Cerci ZC; Sakarya DK; Yetimalar MH; Bezircioglu I; Kasap B; Baser E; Yucel K
Ginekol Pol; 2016; 87(5):326-32. PubMed ID: 27304646
[TBL] [Abstract][Full Text] [Related]
20. Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study.
Harlaar NJ; Koller M; de Jongh SJ; van Leeuwen BL; Hemmer PH; Kruijff S; van Ginkel RJ; Been LB; de Jong JS; Kats-Ugurlu G; Linssen MD; Jorritsma-Smit A; van Oosten M; Nagengast WB; Ntziachristos V; van Dam GM
Lancet Gastroenterol Hepatol; 2016 Dec; 1(4):283-290. PubMed ID: 28404198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
